Table 1:
Patient characteristics in normal-weight PCOS versus Control women.
| Patient Characteristics | PCOS (N=8) |
Control (N=8) |
P value |
|---|---|---|---|
| Age (years) | 25.5±1.4 | 25.5±1.9 | 1.0 |
| BMI (kg/m2) | 22.7±0.7 | 22.4±0.5 | 0.56 |
| Waist size (cm) | 77.3±1.9 | 78.1±1.8 | 0.77 |
| Hip size (cm) | 89.5±1.9 | 91.6±2.1 | 0.47 |
| Serum log total T (ng/dL) | 1.8±0.04 | 1.5±0.04 | 0.002 |
| Serum free T (pg/mL) | 6.1±0.5 | 2.5±0.5 | 0.002 |
| Serum A4 (ng/dL) | 211.1±33.5 | 127.5±14.6 | 0.08 |
| Serum DHT (ng/dL) | 12.0±2.6 | 8.1±0.9 | 0.21 |
| Serum DHEAS (μg/dL) | 213.6±20.1 | 199.9±44.6 | 0.82 |
| Serum E1 (pg/mL) | 80.4±10.4 | 72.0±11.9 | 0.42 |
| Serum E2 (pg/mL) | 59.8±7.6 | 107.0±34.9 | 0.19 |
| Serum LH (mIU/mL) | 17.1±2.8 | 10.8±2.2 | 0.15 |
| Serum FSH (mIU/mL) | 5.5±0.2 | 6.8±0.9 | 0.26 |
| Fasting Plasma Glucose (mg/dL) | 85.4±1.5 | 84.9±2.3 | 0.81 |
| Fasting Serum Insulin (μU/mL) | 6.2±0.8 | 4.3±0.6 | 0.08 |
| Insulin Sensitivity (x10−4/min/U/mL) | 4.9±0.9 | 8.5±2.1 | 0.12 |
| % Android Fat/Total Body Fat | 6.7±0.5 | 5.4±0.2 | 0.016 |
| % Gynoid Fat/Total Body Fat | 20.7±0.3 | 21.6±0.6 | 0.18 |
| Total Body Fat (kg) | 20.0±1.5 | 21.2±0.9 | 0.46 |
| % Total Body Fat/Total Body Mass | 32.1±1.6 | 31.8±1.1 | 0.85 |
Mean ± SEM
Conversion to SI Units: T (X 0.0347 nmol/L), free T (X 3.47 pmol/L), A4 (X 0.0349 nmol/L), DHT (X 0.0344 nmol/L), DHEAS (X 0.0271 μmol/L), E1 (X 3.699 pmol/L), E2 (X 3.67 pmol/L), LH (X 1.0 IU/L), FSH (X 1.0 IU/L), glucose (X 0.0555 mmol/L), insulin (X 7.175 pmol/L)